Abstract
Background: Proteinase-activated receptor 2 (PAR-2) is a G-protein coupled transmembrane receptor activated by trypsin by site-specific cleavage. Its presence on pancreatic structures was demonstrated in the past. PAR-2 physiologically involves in duct/ acinary cells secretion, arterial tonus regulation or capillary liquid turnover. During development of acute pancreatitis/ acute pancreatic lesion (APL) these mentioned structures are influenced by very high concentration of trypsin due to its increased basolateral secretion into the interstitium. The aim of our study as presented was to investigate whether PAR-2 is also involved in APL following changes of PAR-2 expression.
Methods: APL was investigated in Wistar rats after injection of 0.1 mL taurocholate into the ductus choledochus. Anatomy, histology, reverse transcriptase polymerase chain reaction (RT PCR) as well as immunohistochemistry and Western-blot analysis of pancreatic tissue were performed using antibody mapping of the new NH2 terminal of PAR-2 after trypsin cleavage. Results from control rats and d 1 or d 4 rats after taurocholate injection were compared.
Results: Much higher positivity on acinary/ duct cells was observed in APL induced animals than in controls. Similar findings were noticed on arterial smooth muscle cells. Surprisingly, parallel to the exocrine pancreas and vessel findings, enhanced Langerhans’ islet cell positivity was observed in experimental animals.
Conclusions: Based on these results, we have demonstrated that during APL development PAR-2 expression increases. This effect is caused by conformational changes after PAR-2 activation, and the new NH2 terminal of activated receptor presentation. We suggest that PAR-2 physiological functions are enhanced during APL development.
Similar content being viewed by others
References
Thomas C. Histopathology, 8th ed, B.C. Decker Inc., Toronto, Philadelphia, 1989; p. 64.
Rattner DW. Experimental models of acute pancreatitis and their relevance to human disease. Scand J Gastroenterol Suppl 1996;219:6–9.
Cook LJ, Musa OA, Case RM. Intracellular transport of pancreatic enzymes. Scand J Gastroenterol Suppl 1996;219:1–5.
McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83(7):919–923.
Scholmerich J. Interleukins in acute pancreatitis. Scand J Gastroenterol Suppl 1996;219:37–42.
Sweiry JH, Mann GE. Role of oxidative stress in the pathogenesis of acute pancreatitis. Scand J Gastroenterol Suppl 1996;219:10–15.
Bohm S, Kong W, Bunnett NW. Molecular cloning expression and potential function of the human proteinase activated receptor 2. Biochem J 1996;314:1009–1016.
Deri O, Corvera C, Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998;274:C1429-C1452.
Kaufmann R, Schafberg H, Nowak G. Proteinase-activated receptor-2-mediated signaling and inhibition of DNA synthesis in human pancreatic cancer cells. Int J Pancreatol 1998;24(2):97–102.
Nysted S, Emilsson K, Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor-2. Eur J Biochem 1995;232:84–89.
Saudek F, Cihalova E, Karasova L, Kobylka P, Lomsky R. Increased glucagon-stimulated insulin secretion of cryo-preserved rat islets transplanted into nude mice. J Mol Med 1999;77(1):107–110.
Saudek F, Kazdova L, Nozickova M, Vrana A, Cihalova E, Ruzbarsky V. The effect of combination therapy with cyclosporine A and hydrocortisone on glucose metabolism in diabetic rats following pancreatic islet transplantation. Physiol Res 1995;44(2):79–86.
Smith-Swintosky VL, Cheo-Isaacs CT, D’Andrea MR, Santulli RJ, Darrow AL, Andrade-Gordon P. Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J Neurochem 1997;69(5):1890–1896.
Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001;53(2):245–82.
Santa Cruz Biotechnology, Inc., Data on file. SC-8207; www.sclot.com
Kong W, McConalogue K, Bunnet NW. Luminal trypsin may regulate enterocytes through proteinase activatedrecptor 2. Proc Natl Acad Sci USA 1997;94:8884–8889.
Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS, Bunnett NW. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 1999;103(2):261–269.
Kawabata A, Nishikawa H, Kuroda R, Kawai K, Hollenberg MD. Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br J Pharmacol 2000;129(8):1808–1814.
D Andrea MR, Rogahn CJ, Andrade-Gordon P. Localisation PAR-1 and PAR-2 in human mast cells: indications for an amplified mast cell degranulation cascade. Biotech Histochem 2000;75(2):85–90.
Sharlow ER, Paine CS, Babiarz L, Eisinger M, Shapiro S, Seiberg M. The protease-activated receptor-2 upregulates keratinocyte phagocytosis. J Cell Sci 2000;113(Pt 17):3093–3101.
Seiberg M, Paine C, Sharlow E, et al. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000;10;254(10):25–32.
Belham CM, Tate RJ, Scott PH, et al. Trypsin stimulates proteinase-activated receptor-2-dependent and-independent activation of mitogen-activated protein kinases. Biochem J 1996;329(Pt 3):939–46.
Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, Laurent GJ. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 2000;275(45):35584–35591.
Beynon RJ, Kay J. Enteropancreatic circulation of digestive enzyme. Nature 1976;260(5546):78–90.
Heinrich HC, Gabbe EE, Bruggemann J, Icagic F, Classen M. Enteropancreatic circulation of trypsin in man. Klin Wochenschr 1979;57(23):1295–1297.
Grandaliano G, Monno R, Ranieri E, et al. Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 2000;11(6):1016–1025.
Malka D, Hammel P, Sauvanet A, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000;119(5):1324–1332.
Toyama MT, Lewis MP, Kusske AM, Reber PU, Ashley SW, Reber HA. Ischaemia-reperfusion mechanisms in acute pancreatitis. Scand J Gastroenterol Suppl. 1996;219:20–23.
Moffatt JD, Cocks TM. Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries. Br J Pharmacol 1998;125(4):591–594.
Cheung WM, Andrade-Gordon P, Derian CK, Damiano BP. Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo. Can J Physiol Pharmacol 1998;76(1):16–25.
Cicala C, Pinto A, Bucci M, et al. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 1999;99(19):2590–2597.
Kawabata A, Kuroda R, Minami T, Kataoka K, Taneda M. Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br J Pharmacol 1998;125(3):419–422.
Mari B, Guerin S, Far DF, et al. Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J 1996;19(2):309–316.
Howells GL, Macey MG, Chinni C, et al. Proteinase-activated receptor-2: expression by human neutrophils. J Cell Sci 1997;110(Pt 7):881–887.
Wakita H, Furukawa F, Takigawa M. Thrombin and trypsin induce granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes. Proc Assoc Am Physicians 1997;109(2):190–207.
McKay C, Imrie CW, Baxter JN. Mononuclear phagocyte activation and acute pancreatitis. Scand J Gastroenterol Suppl 1996;219:32–36.
Akers IA, Parsons M, Hill MR, et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol 2000;278(1):L193–201.
Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991;88(2):493–499.
Chen YZ, Ikei S, Yamaguchi Y, et al. The protective effects of long-acting recombinant human pancreatic secretory trypsin inhibitor (R44S-PSTI) in a rat model of cerulein-induced pancreatitis. Int Med Res 1996;24(1):59–68.
Maruyama N, Hirano F, Yoshikawa N, Migita K, Eguchi K, Tanaka H. Thrombin stimulates cell proliferation in human fibroblast-like synoviocytes in nuclear factor-kappaB activation and protein kinaseC mediated pathway. J Rheumatol 2000;27(12):2777–2785.
Moriyama S, Ayson FG, Kawauchi H. Growth regulation by insulin-like growth factor-1 in fish. Biosci Biotechnol Biochem 2000;64(8):1553–1562.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olejár, T., Matěj, R., Zadinová, M. et al. Expression of proteinase-activated receptor 2 during taurocholate-induced acute pancreatic lesion development in wistar rats. Int J Gastrointest Canc 30, 113–121 (2001). https://doi.org/10.1385/IJGC:30:3:113
Issue Date:
DOI: https://doi.org/10.1385/IJGC:30:3:113